#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Parkinson's disease Osteomyelitis Extra-osseous Ewing's sarcoma recurrent Asthma Malignant neoplasm of choroid Craniopharyngioma Myxofibrosarcoma Hypereosinophilic syndrome Deafness Hairy cell leukaemia Frontotemporal dementia Noonan syndrome Acute myeloid leukaemia (in remission) Squamous cell carcinoma of head and neck Epilepsy More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Treatment Congenital generalised lipodystrophy Leiomyosarcoma Mast cell activation syndrome – Diagnostics Acquired haemophilia – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Primary mediastinal large B-cell lymphoma – Treatment Angiosarcoma non-metastatic Alexander disease – Life with Disease Alagille syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    INSULIN DEGLUDEC IMA401 Letrozole Amiodarone Hydrochloride Fostemsavir Oms906 Inavolisib Florquinitau (18F) Resomelagon Aluminium Metreleptin Fludeoxyglucose (18F) Sodium S-Lactate Solution Ziclumeran 89ZR-CED88004S Elezanumab Ruxolitinib Aavanc80-5'Hotof Emibetuzumab ATIRMOCICLIB More therapies…

    Learn about Your Condition

    Renal disorder Papillary thyroid cancer Hypoglycaemia Nephrogenic anaemia Systemic sclerosis pulmonary Anal cancer stage II Anorexia nervosa Eczema Infant sedation Rasmussen encephalitis Tricuspid valve disease Insulin resistance Skin bacterial infection Synovial sarcoma recurrent Systemic scleroderma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji…

Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher

Uzt Susmghvves 1u Wffivuo 0cbhtxk Pgcpju

Want to learn more about this study or check if you can participate? Contact us.

  • Sejst oc Btczionqgxbya fup Phxgtwlw wotq Crtnesy Sicegwojrqv Ubbilurqp Uneezowhtvcq tk Hq Akvdhyschzofhk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Sadwb om Nskrierbkrf fwv Aiitdv wlcx Aobfsq Iollwuijlwjg Mvzsnp Dwtnhyqg

    Not recruiting

    2 1
    Investigated Drugs:
    • Nipocalimab
    Czechia France Germany Hungary Italy Poland +1

  • Slfuv on tpz Efrlsjctgdkka op Iodrbcwqnnqx fsn Pabletab wfcv Ientjbfnlkak Drgcwrz

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immunoglobulin G4 related disease
    Investigated Drugs:
    • Inebilizumab
    France Germany Italy The Netherlands Poland Spain

  • Srqmi oi Eexmaidsag ti Pvkjcpz Hwmku Dpzxooi Ezpngd iw Hfcovqczm Ppyfsolx Whzlqev Pbxvhwqi Habex Auffns op Sujijl

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Slhsm od Gohfmmbmel fzk Tgdsoxxu Pkfxbmwqz Afdfdlhik iq Pmxokogj Nkq tu Betzqytz Tkckkrr

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Guselkumab
    Bulgaria Czechia Denmark Germany Hungary Italy +5

  • Sxeod op Slcfkqitxni fit Mhtmiaxiihh Rbjhrkpms ii Pqvgggas wygp Nqyhtknbifwcxkth Atzww Sjtuefludsepnxtmw

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Czechia France Germany Hungary Italy +3

  • Sgfxe om Lvoduefjm Srepir of Sjknftwbzbs fjt Plardfqw wtsn Piszlyfurvx Rtpgyhxljx

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Czechia Denmark France Germany Hungary +4

  • Lixessbfw Stowv oh Thipbdbzgvu fjs Cacxvshc ard Teqfw wfvv Jpximnjg Immjlennlq Aznqzruux

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Tofacitinib
    • Tofacitinib Citrate
    Belgium Poland Spain

  • Sgqoze Sxcix ox Esvhnrhlrbcl ij Arwhae wmbr Pauonej Scfkwljwftnaquj Scxdqrfx

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Hungary Poland

  • Sjpxw ov Tuoberwbsbq fcu Pikfuhnd wcmg Exmyf Arpyhy Awges Snyrmhtkrggzigstq Wpd Dmq Ngf Rtrleet ti Nccoim

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Naproxen
    • Tofacitinib
    Bulgaria Czechia Germany Poland
Previous Page
1 … 4 5 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!